证券代码：688386 证券简称：泛亚微透 公告编号：2023-039 江苏泛亚微透科技股份有限公司 第三届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司（以下简称"公司"）第三届监事会第十三 次会议通知于2023年 8月18日以直接送达、微信等方式发出，并通过电话进行确 认，会议于2023年8月28日在公司会议室以现场会议方式召开。会议应出席监事3 名，实际出席监事3名。会议由监事会主席张斌先生主持。本次会议的召集、召开和表 决程序符合《公司法》、《公司章程》的规定，合法有效。 经与会监事逐项认真审议，会议以记名投票表决的方式通过了如下议案： 2、审议通过了《关于2023年半年度募集资金存放与实际使用情况的专项 报告的议案》 监事会认为：公司编制的《2023 年半年度募集资金存放与实际使用情况的 专项报告》符合相关法律法规的要求，真实地反映了报告期内募集资金的存放 与实际使用情况。不存在变相改变募集资金投向和损害公司及全体股东利益的 情形。 表决结果：同意3票； ...

江苏泛亚微透科技股份有限公司独立董事 关于第三届董事会第十三次会议相关事宜的独立意见 江苏泛亚微透科技股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开公司第三届董事会第十三次会议。根据《中华人民共和国公司法》、公司 内部规定并参照上市公司相关制度等相关规定，我们作为公司的独立董事，在审 阅有关文件资料后，对公司第三届董事会第十三次会议审议的相关事项，基于独 立判断的立场，发表意见如下： 一、关于2023年半年度募集资金存放与使用情况的独立意见 公司独立董事审阅了《关于2023年半年度募集资金存放与实际使用情况的 专项报告》，并发表了以下独立意见： 经核查，公司2023年半年度募集资金的存放和使用符合中国证监会、上海 证券交易所关于上市公司募集资金存放和使用的相关监管要求和管理办法，不存 在募集资金存放和使用违规的情形。公司所披露的募集资金存放和使用情况信息 与实际情况一致，如实履行了信息披露义务。 （以下无正文） （本页无正文，为《江苏泛亚微透科技股份有限公司独立董事关于第三届董事会 第十三次会议相关事宜的独立意见》之签字页） 独立董事签字： 许明强： 陈 强： 钱技平： 2023 年 ...

证券代码：688386 证券简称：泛亚微透 公告编号：2023-038 江苏泛亚微透科技股份有限公司 第三届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司（以下简称"公司"或"泛亚微透"）第 三届董事会第十三次会议（以下简称"会议"）于2023年8月18日以直接送达、 微信等方式发出通知，并通过电话进行确认，会议于2023年8月28日以现场加视 频会议方式召开。会议应出席董事9名，实际出席董事9名，会议由董事长张云 先生主持，本次会议的召集、召开和表决程序符合有关法律、法规和《公司章 程》的规定，会议形成的决议合法有效。 经与会董事认真审议，以记名投票表决方式审议通过了如下议案： 董事会 2023年8月29日 1 具体内容详见公司同日刊登于上海证券交易所网站 (www.sse.com.cn) 的 《泛亚微透2023年半年度报告》及《泛亚微透2023年半年度报告摘要》。 2、审议通过了《关于2023年半年度募集资金存放与实际使用情况的专项 报告的议案》 表决结果：9 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥77,414,260.29, representing a year-on-year increase of 2.91%[4] - The net profit attributable to shareholders decreased by 35.90% to ¥11,539,385.39 compared to the same period last year[4] - Total operating revenue for Q1 2023 was CNY 77,414,260.29, a 2.6% increase from CNY 75,226,296.26 in Q1 2022[15] - Net profit for Q1 2023 was CNY 13,324,376.81, a decrease of 26.5% compared to CNY 18,090,454.47 in Q1 2022[16] - The company reported a total comprehensive income of CNY 13,324,376.81 for Q1 2023, a decrease from CNY 18,090,454.47 in the previous year[16] Cash Flow - The net cash flow from operating activities fell by 74.37% to ¥7,058,625.59, primarily due to tax payments related to the previous year[6] - Cash flow from operating activities generated a net amount of CNY 7,058,625.59, down 74.5% from CNY 27,543,050.89 in the previous year[20] - Cash flow from investing activities showed a net outflow of CNY 20,300,374.15, compared to a net outflow of CNY 158,388,711.31 in Q1 2022[21] - Cash flow from financing activities resulted in a net outflow of CNY 5,743,266.67, compared to a net outflow of CNY 1,405,375.00 in the same period last year[21] - The ending balance of cash and cash equivalents was CNY 87,103,366.54, compared to CNY 40,682,977.38 at the end of Q1 2022[21] Research and Development - Research and development expenses totaled ¥5,497,392.77, an increase of 46.77% year-on-year, accounting for 7.10% of operating revenue[4][5] - Research and development expenses rose to CNY 5,497,392.77, representing a 46.8% increase from CNY 3,745,592.45 in Q1 2022[15] Assets and Liabilities - Total assets at the end of the reporting period were ¥901,956,859.56, reflecting a 1.15% increase from the end of the previous year[5] - The company's current assets totaled RMB 386,854,055.46, compared to RMB 379,454,266.08 at the end of 2022, indicating an increase of about 1.1%[12] - The total liabilities decreased to RMB 241,389,492.21 from RMB 244,484,838.11, showing a decrease of approximately 1.3%[14] - The company's equity attributable to shareholders increased to RMB 629,082,669.86 from RMB 617,543,284.47, reflecting a growth of about 1.8%[14] - The total equity increased to RMB 660,567,367.35 from RMB 647,242,990.54, marking an increase of about 2.1%[14] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 3,877[9] - The top shareholder, Zhang Yun, holds 27.87% of the shares, totaling 19,511,467 shares[9] Operational Strategy - The company does not anticipate any significant changes in its operational strategy for the upcoming quarters[6]

Financial Performance - The company's operating revenue for 2022 was CNY 364,464,300.36, representing a 15.11% increase compared to CNY 316,615,240.65 in 2021[21]. - The net profit attributable to shareholders for 2022 was CNY 31,344,909.48, a decrease of 52.79% from CNY 66,398,200.58 in 2021[22]. - The net cash flow from operating activities for 2022 was CNY 79,136,698.62, down 2.87% from CNY 81,470,932.14 in 2021[22]. - The basic earnings per share for 2022 was CNY 0.45, a decline of 52.63% compared to CNY 0.95 in 2021[23]. - The company recorded a goodwill impairment of CNY 45,727,700 due to the underperformance of a subsidiary acquired in 2021, impacting various financial metrics[23]. - The company experienced a significant decline in net profit in the fourth quarter of 2022, reporting a loss of CNY 11,429,173.58 attributable to shareholders[25]. - The net profit attributable to shareholders decreased by 52.79% year-on-year, primarily due to goodwill impairment from the acquisition of a subsidiary, while excluding this factor, the net profit increased by 16.08% to 77.07 million RMB[34]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 5.00 RMB per 10 shares, totaling 35 million RMB, which accounts for 111.66% of the net profit attributable to shareholders in 2022[5]. - The company has not proposed any stock bonus or capital reserve transfer to increase share capital for the year 2022[5]. Governance and Compliance - The company has confirmed that all board members attended the board meeting, ensuring the integrity of the report[7]. - The company has received a standard unqualified audit report from Tianjian Accounting Firm[7]. - The company has not violated any decision-making procedures regarding external guarantees[8]. - The company has not experienced any changes in its governance structure that would affect the report's accuracy[8]. - The company has established a solid governance structure, ensuring compliance with relevant laws and regulations, and maintaining operational independence[178]. - The company has established a board of directors with three independent directors who provide independent opinions on decision-making[180]. - The supervisory board consists of three members, including one chairman and one employee representative, complying with legal requirements[180]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate communication with shareholders[180]. Research and Development - The company invested 17.18 million RMB in R&D, accounting for 4.71% of operating revenue, and added 16 new patents in 2022[35]. - The company has a strong focus on R&D, continuously improving ePTFE membrane technology to expand its applications across various industries[68]. - The company has established a comprehensive patent system, making it difficult for competitors to replicate its products due to high technical and legal risks[105]. - The company is actively collaborating with universities to enhance its innovation capabilities in new materials and technologies[105]. - The company has reported a significant increase in R&D efforts, with 1,200 samples developed for various applications, including automotive and communication sectors[110]. - The company is committed to increasing its R&D capabilities and converting innovations into patented technologies to strengthen its competitive edge[172]. Market and Product Development - The company is actively involved in the hydrogen energy industry through the establishment of Jiangsu Yuan Hydrogen New Energy Technology Co., focusing on key materials for proton exchange membranes[36]. - The company’s core products include ePTFE membranes and SiO2 aerogels, which are applied in various industries including automotive and consumer electronics[37]. - The company plans to expand its product applications into medical, communication, and military sectors, leveraging its technological advancements[171]. - The company aims to enhance its market position by exploring niche markets and increasing the number of targeted segments[171]. - The company is focusing on expanding its market presence and enhancing its product offerings through strategic leadership[187]. Operational Risks and Challenges - The company has faced various operational risks, which are detailed in the management discussion and analysis section of the report[4]. - The company faced risks related to high customer concentration, primarily in the automotive industry[129]. - The company experienced a decrease in cash flow from financing activities by 108.72%, attributed to no dividends and no new bank loans[142]. Employee and Leadership Structure - The company has a diverse leadership team with extensive experience across various industries, including finance, manufacturing, and technology[187]. - The total pre-tax compensation for all directors and supervisors amounted to 4.86 million yuan[186]. - The company has experienced a change in personnel, with the resignation of the technical director, Song Haimin[193]. - The company has established a performance evaluation process to determine the performance-based salary for its management[192]. Strategic Initiatives - The company has implemented a restricted stock incentive plan in 2022 to motivate and retain key technical and business personnel[174]. - The company has proposed to establish a joint venture for the construction of a hydrogen fuel cell proton exchange membrane project[184]. - The company plans to maintain high R&D investment levels to support new product development despite inherent risks[125].

江苏泛亚微透科技股份有限公司 证券代码：688386 证券简称：泛亚微透 公告编号：2023-019 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 04 月 03 日(星期一) 至 04 月 10 日(星期一)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zhangquan@microvent.com.cn 进行提问。公司将在说明会上对投资者普遍关注 的问题进行回答。 江苏泛亚微透科技股份有限公司（以下简称"公司"）已于 2023 年 3 月 25 日发布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年 度经营成果、财务状况，公司计划于 2023 年 04 月 11 日 下午 15:00-16:00 举 行 2022 年度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥99,306,634.64, representing a year-on-year increase of 45.38%[5] - The net profit attributable to shareholders for Q3 2022 was ¥16,373,054.66, reflecting a significant increase of 73.25% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥15,765,995.84, up 86.27% year-on-year[5] - Basic and diluted earnings per share for Q3 2022 were both ¥0.23, an increase of 64.29% compared to the previous year[6] - The net profit attributable to shareholders for the year-to-date period was ¥42,802,440.58, showing a slight decrease of 1.43% compared to the previous year[5] - Total operating revenue for the first three quarters of 2022 reached ¥245,570,860.75, an increase of 16.5% compared to ¥210,863,015.22 in the same period of 2021[21] - Total operating costs for the first three quarters of 2022 were ¥200,519,535.60, up 20.9% from ¥165,715,207.84 in the previous year[21] - Net profit for the third quarter of 2022 was ¥42,431,872.47, slightly down by 2.0% from ¥43,318,884.04 in the same quarter of 2021[22] Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥903,957,256.90, marking a 4.74% increase from the end of the previous year[6] - As of September 30, 2022, total assets amounted to RMB 903,957,256.90, an increase from RMB 863,010,668.04 at the end of 2021[18] - Current assets decreased to RMB 347,026,015.12 from RMB 424,426,347.28 year-over-year, reflecting a decline of approximately 18.2%[16] - Total liabilities decreased to RMB 236,291,718.05 from RMB 247,140,944.50, a reduction of about 4.0%[19] - The company's equity increased to RMB 667,665,538.85 from RMB 615,869,723.54, reflecting a growth of approximately 8.4%[19] Cash Flow and Investments - Cash flow from operating activities for the first three quarters of 2022 was ¥57,484,160.80, an increase of 10.5% from ¥51,857,020.21 in the same period of 2021[26] - Cash received from sales of goods and services in the first three quarters of 2022 was ¥235,273,147.91, up 22.5% from ¥192,029,057.43 in the previous year[26] - The company recorded a significant cash inflow from investment activities of ¥374,512,559.91 in the first three quarters of 2022, compared to ¥755,715,319.13 in the same period of 2021[26] - The net cash flow from investment activities was -149,257,125.45, compared to -174,511,187.56 in the previous period, indicating a slight improvement[27] - Cash inflow from financing activities totaled 49,500,000.00, down from 183,000,000.00 in the previous period, reflecting a decrease in financing received[27] - The total cash and cash equivalents at the end of the period were 76,480,102.70, down from 98,303,413.90 previously, indicating a decrease in liquidity[27] - The net increase in cash and cash equivalents was -96,488,296.98, compared to -25,739,948.17 in the previous period, highlighting a worsening cash position[27] - The cash outflow from investment activities was 523,769,685.36, compared to 930,226,506.69 in the previous period, showing a reduction in investment spending[27] Research and Development - Research and development expenses totaled ¥4,454,341.89, accounting for 4.49% of operating revenue, a decrease of 2.05 percentage points year-on-year[6] - Research and development expenses for the first three quarters of 2022 amounted to ¥12,182,632.42, compared to ¥11,868,615.56 in the same period of 2021, reflecting a growth of 2.6%[22] Operational Context - The company experienced a recovery in business operations due to the easing of the pandemic in Shanghai and other regions, positively impacting the automotive supply chain[10] Other Financial Metrics - The weighted average return on equity was 2.58%, an increase of 0.89 percentage points compared to the same period last year[6] - The company recognized a total of ¥607,058.82 in non-recurring gains for the current period, with government subsidies contributing significantly to this figure[9] - The deferred tax assets increased to RMB 4,204,877.68 from RMB 2,353,192.43, reflecting a growth of approximately 78.7%[18] - The long-term investments in fixed assets rose to RMB 255,814,513.43 from RMB 232,927,690.09, an increase of about 9.8%[16] - The company reported a significant increase in accounts receivable, which rose to RMB 123,391,061.59 from RMB 111,809,653.01, an increase of approximately 10.3%[16] - The cash paid for debt repayment was 50,000,000.00, slightly up from 49,500,000.00 in the previous period, indicating stable debt servicing[27] - The cash paid for dividends and interest was 4,257,706.92, down from 36,454,697.22, reflecting a reduction in shareholder returns[27] - The company has maintained a stable capital structure with a paid-in capital of RMB 70,000,000.00, unchanged from the previous year[19] - The company has not adopted new accounting standards, maintaining consistency in financial reporting[27]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥146.26 million, a 2.60% increase compared to ¥142.55 million in the same period last year[21]. - The net profit attributable to shareholders decreased by 22.20% to ¥26.43 million from ¥33.97 million year-on-year[21]. - The net cash flow from operating activities increased significantly by 73.53% to ¥55.36 million, driven by increased collections and government subsidies[22]. - The company's net assets at the end of the reporting period rose by 5.31% to ¥617.31 million from ¥586.20 million at the end of the previous year[21]. - The basic earnings per share decreased by 22.45% to ¥0.38 from ¥0.49 in the same period last year[21]. - The total comprehensive income for the first half of 2022 was CNY 26,429,385.92, with a decrease of CNY 126,479.08 compared to the previous period[174]. - The total profit for the first half of 2022 was CNY 30,031,020.03, a decrease of 21.7% from CNY 38,415,062.23 in the first half of 2021[162]. - The company's operating profit for the first half of 2022 was CNY 30,031,369.59, down from CNY 38,469,033.18 in the same period of 2021[162]. Research and Development - Research and development expenses accounted for 5.28% of operating revenue, slightly up from 5.19% year-on-year[21]. - The company has obtained a total of 212 authorized patents as of June 30, 2022, with 8 new patents granted during the reporting period[42]. - The company has invested a total of RMB 2,941.89 million in various research projects, with a current period investment of RMB 772.83 million[51]. - The number of R&D personnel has increased to 56, representing 16.57% of the total workforce, up from 13.38% in the previous year[53]. - The company has collaborated with multiple enterprises to draft two group standards for aerogel products, promoting industry development and new applications[42]. - The company has made significant advancements in modifying ePTFE membranes, enhancing their performance characteristics for various applications[41]. - The company has submitted multiple patent applications for innovative composite materials, indicating a strong commitment to R&D and market expansion[51]. Operational Risks and Management - The company has detailed various operational risks and corresponding countermeasures in the report[5]. - The company faces risks related to high customer concentration, primarily serving domestic joint ventures and independent brand automakers[70]. - The company is closely monitoring the impact of the ongoing COVID-19 pandemic on its operations and the broader economy[79]. - The company has not reported any significant changes in the capitalized R&D investment ratio during the reporting period[46]. Corporate Governance and Compliance - The financial report has been declared to be true, accurate, and complete by the responsible persons of the company[6]. - The company has not violated decision-making procedures for providing guarantees[10]. - The company has committed to transparency in its financial disclosures, with reports available on the Shanghai Stock Exchange website[19]. - The company has established necessary environmental protection facilities, ensuring that waste gas is organized and discharged, and wastewater is treated at a municipal sewage treatment plant[102]. - The company has committed to not transferring or entrusting its shares for six months following the IPO, which includes shares held prior to the issuance[111]. Shareholder Information - The largest shareholder, Zhang Yun, holds 19,511,467 shares, representing 27.87% of the total shares[136]. - The second largest shareholder, Changzhou Saifu High-tech Investment Center, holds 8,094,724 shares, accounting for 11.56%[136]. - The total number of ordinary shareholders as of the end of the reporting period was 3,889[134]. - The company has a lock-up period for shares held by major shareholders, with Zhang Yun's shares becoming tradable on October 16, 2023, after a 36-month lock-up[140]. Investment and Capital Structure - The company has temporarily used idle raised funds to purchase financial products, with a total actual income of 284,134.23 yuan from various structured deposit products[131]. - The project for high water-resistant ePTFE modified membrane has an investment commitment of 63 million yuan, with 35,780,930.18 yuan invested, representing a progress of 56.80%[128]. - The SiO2 aerogel and ePTFE composite material project has a total investment commitment of 112 million yuan, with 74,530,262.96 yuan invested, achieving a progress of 90.37%[128]. - The company has established a joint venture for the development of ePTFE functional membranes and hydrogen fuel cell technology, with a registered capital of ¥100 million[89]. Market and Product Development - The company continues to focus on the automotive industry, which has been impacted by supply chain disruptions due to the pandemic[21]. - The company is expanding its product applications into healthcare and power communication sectors, leveraging its core technologies[26]. - The company is focusing on the automotive industry's transition to new energy and intelligence, positioning itself for future growth[62]. - The company has established stable partnerships with well-known domestic and international automotive lighting manufacturers for its ePTFE membrane products[28]. Financial Position - Cash and cash equivalents decreased by 53.00% to ¥81,288,334.89, compared to ¥172,968,399.68 at the end of the previous year[87]. - Total assets increased from ¥863,010,668.04 to ¥879,066,783.23, a growth of about 1.9%[152]. - Total liabilities decreased from ¥247,140,944.50 to ¥232,212,181.43, a decrease of approximately 6%[152]. - Shareholders' equity increased from ¥615,869,723.54 to ¥646,854,601.80, an increase of about 5%[152].

Financial Performance - The company achieved operating revenue of RMB 316.62 million in 2021, representing a year-on-year increase of 14%[20]. - Net profit attributable to shareholders reached RMB 66.40 million, up 20.13% compared to the previous year[20]. - The company reported a total revenue of 4,301.33 million RMB, with a gross profit of 1,810.10 million RMB, resulting in a gross margin of approximately 42.1%[103]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the fiscal year, representing a 20% year-over-year growth[190]. - The gross margin improved to 45%, up from 40% in the previous year, reflecting better cost management and pricing strategies[190]. - The company reported a net profit of 300 million RMB, a 15% increase compared to the last fiscal year[190]. Research and Development - Research and development expenses accounted for 5.72% of operating revenue, an increase of 0.36 percentage points from the previous year[21]. - R&D investment reached 18.101 million yuan, a year-on-year increase of 21.56%[31]. - The number of R&D personnel expanded to 61, accounting for 16.58% of total employees[31]. - The company obtained 18 new patents during the reporting period, bringing the total number of patents to 204[99]. - The company is investing in research and development to innovate and improve its product offerings, aiming for a competitive edge in the market[187]. Market Position and Strategy - The company operates in a niche market characterized by high technical barriers and high gross margins[12]. - The company’s strategic focus includes expanding into automotive, consumer electronics, and military sectors, with significant breakthroughs in new business development and technology research[30]. - The company aims to expand its product applications in medical, communication, and military sectors, leveraging its core technologies of ePTFE and SiO2 aerogel[162]. - The company is focusing on diversifying its product offerings and expanding into new markets, including consumer electronics and renewable energy[165]. - The company plans to maintain high R&D investment levels, despite the inherent risks associated with new product development and market competition[113]. Operational Efficiency - The company primarily adopts a self-production model, with some simple labor-intensive products outsourced to improve operational efficiency[56]. - The production plan is based on customer orders, considering capacity load, raw materials, and equipment, ensuring timely delivery[57]. - The company is committed to improving management efficiency and profitability through cost control and innovative management practices[167]. - The company has established a comprehensive supply chain management system, ensuring the quality and stability of raw material supply through long-term partnerships[55]. Risks and Challenges - The company faces various operational risks, which are detailed in the "Management Discussion and Analysis" section of the report[4]. - The company is exposed to raw material price volatility, particularly due to fluctuations in oil prices affecting key inputs[118]. - The company faces risks related to high customer concentration, primarily relying on major automotive manufacturers for sales[117]. - The company faced risks related to macroeconomic uncertainties, including potential impacts from geopolitical tensions and the ongoing effects of the COVID-19 pandemic[125]. Governance and Compliance - The company is committed to ensuring the authenticity, accuracy, and completeness of the annual report, with all board members present at the meeting[8]. - The company strictly adheres to legal regulations for information disclosure, ensuring timely and accurate communication with investors[176]. - The company has established a strong governance structure and has complied with relevant laws and regulations to ensure operational transparency[170]. - The board of directors and supervisory board were re-elected during the 2021 annual general meeting[176]. Acquisitions and Investments - The company acquired 60% of Dayin Xisheng's equity in cash, expanding its aerogel business into the military sector[34]. - The company acquired 60% of Shanghai Dayin Xisheng New Materials Co., Ltd., which began contributing to consolidated financials from September 2021[140]. - The company invested 100 million yuan in the hydrogen fuel cell proton exchange membrane project, funded by its own capital[122]. - The company has announced a strategic acquisition of a local competitor, valued at 300 million RMB, aimed at increasing production capacity and market reach[190]. Product Development and Innovation - The company focuses on the development of advanced materials such as ePTFE and aerogels, which have unique properties for various applications[12]. - The company has developed various innovative products, including breathable plugs and membranes, which have been successfully applied in multiple industries[162]. - The company has made significant advancements in ePTFE membrane composite technology, improving breathability and structural strength[96]. - The company is conducting research on aerogel insulation materials for electric vehicles, with a total investment of ¥1,500,000[100]. Financial Health - The company has a registered capital of 100 million RMB and is located in Changzhou, Jiangsu Province[14]. - The company has received a standard unqualified audit report from Tianjian Accounting Firm[8]. - Cash and cash equivalents increased by 39.44% to 172,968,399.68, reflecting improved cash management[152]. - The company reported a significant increase in goodwill to 113,009,826.91 due to the acquisition of Da Yin Xi Sheng[152].

Financial Performance - The company's operating revenue for Q1 2022 was ¥75,226,296.26, representing a year-on-year increase of 9.50%[4] - The net profit attributable to shareholders was ¥18,002,002.72, reflecting an increase of 11.98% compared to the same period last year[4] - The basic earnings per share for the period was ¥0.26, an increase of 11.98% year-on-year[4] - Net profit for Q1 2022 reached CNY 18,090,454.47, representing a 12.5% increase from CNY 16,075,966.83 in Q1 2021[18] - Earnings per share for Q1 2022 were CNY 0.26, compared to CNY 0.23 in Q1 2021, indicating a growth of 13%[18] - The company reported a total comprehensive income of CNY 18,090,454.47 for Q1 2022, compared to CNY 16,075,966.83 in Q1 2021[18] Cash Flow - The net cash flow from operating activities was ¥27,543,050.89, showing a significant increase of 53.33%[4] - The net cash flow from operating activities was 27,543,050.89, an increase from 17,963,591.29 in the previous year, reflecting a growth of approximately 53.5%[21] - The total cash inflow from operating activities was 83,856,379.51, compared to 64,819,484.84 in the previous year, showing an increase of about 29.3%[21] - The total cash outflow from operating activities was 56,313,328.62, up from 46,855,893.55 in the previous year, reflecting an increase of approximately 20.5%[21] - Cash received from sales of goods and services in Q1 2022 was CNY 77,893,560.91, an increase of 22.8% from CNY 63,477,825.22 in Q1 2021[20] - The ending balance of cash and cash equivalents was 40,682,977.38, a decrease from 155,313,827.86 in the previous year, representing a decline of approximately 73.8%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥865,086,910.33, a slight increase of 0.24% from the end of the previous year[5] - Current assets decreased to RMB 303,529,227.07 from RMB 424,426,347.28, representing a decline of approximately 28.5%[12] - Non-current assets rose to RMB 561,557,683.26 from RMB 438,584,320.76, an increase of approximately 28%[13] - Total liabilities as of Q1 2022 amounted to CNY 231,126,732.31, down from CNY 247,140,944.50 in the previous year[14] - Accounts payable decreased to RMB 37,550,995.78 from RMB 51,552,345.39, a decline of approximately 27%[13] Research and Development - Research and development expenses totaled ¥3,745,592.45, which is a decrease of 11.75% year-on-year, and accounted for 4.98% of operating revenue, down by 1.20 percentage points[4] - Research and development expenses for Q1 2022 were CNY 3,745,592.45, a decrease of 11.8% compared to CNY 4,244,417.16 in Q1 2021[17] Market and Strategy - The company has not reported any significant new product developments or market expansion strategies during this quarter[11] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[19] Other Financial Metrics - The weighted average return on equity was 3.02%, an increase of 0.16 percentage points compared to the previous year[4] - The company reported non-recurring gains and losses totaling ¥4,366,162.43 after tax[5] - Total operating costs for Q1 2022 were CNY 58,338,725.76, up from CNY 51,661,796.08 in Q1 2021, reflecting a year-over-year increase of 12.9%[17] - The company experienced a significant increase in prepayments, which rose by 180.51% due to increased advance payments to suppliers[7]